Ryan Specialty (NYSE:RYAN) Given New $35.00 Price Target at Piper Sandler

Key Points

• Piper Sandler cut its price target on Ryan Specialty from $43 to $35 and kept a "neutral" rating, while several other brokers also trimmed targets; the consensus remains a "Hold" with an average price target of $47.47.
• Shares fell to $31.14 on heavy volume (3.66M vs. avg 2.11M), trading near their 12‑month low and carrying a high PE (~74.4), reflecting recent analyst downgrades and selling pressure.
• Operationally, Ryan beat Q1 expectations with $0.47 EPS vs. $0.43 and revenue of $795.2M (up 15.2% YoY), announced a $0.13 quarterly dividend, and saw a director buy 25,500 shares, suggesting underlying momentum despite mixed sentiment.

Ryan Specialty (NYSE:RYAN - Get Free Report) had its price target dropped by research analysts at Piper Sandler from $43.00 to $35.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Piper Sandler's price target would indicate a potential upside of 12.40% from the company's current price.

Other analysts also recently issued reports about the company. Zacks Research downgraded Ryan Specialty from a "hold" rating to a "strong sell" rating in a research note on Tuesday, February 24th. Barclays reduced their price target on Ryan Specialty from $41.00 to $39.00 and set an "overweight" rating for the company in a research note on Friday. Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $49.00 to $42.00 and set an "outperform" rating for the company in a research note on Friday. Mizuho set a $35.00 price target on Ryan Specialty in a research note on Friday. Finally, Weiss Ratings downgraded Ryan Specialty from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of "Hold" and an average price target of $47.47.

Ryan Specialty Stock Performance

Shares of RYAN stock traded down $3.63 during trading on Friday, reaching $31.14. 3,655,145 shares of the company's stock were exchanged, compared to its average volume of 2,105,130. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. The stock has a market capitalization of $8.23 billion, a PE ratio of 74.44, a PEG ratio of 0.95 and a beta of 0.71. Ryan Specialty has a twelve month low of $29.91 and a twelve month high of $72.50. The firm's fifty day moving average price is $36.08 and its 200-day moving average price is $46.46.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. The business had revenue of $795.23 million for the quarter, compared to analyst estimates of $781.44 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The firm's revenue was up 15.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.39 EPS. As a group, sell-side analysts anticipate that Ryan Specialty will post 2.24 EPS for the current year.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the business's stock in a transaction dated Monday, February 23rd. The shares were purchased at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the transaction, the director owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 52.03% of the company's stock.

Institutional Investors Weigh In On Ryan Specialty

A number of large investors have recently made changes to their positions in RYAN. Los Angeles Capital Management LLC purchased a new position in shares of Ryan Specialty in the 4th quarter valued at approximately $25,000. Advisory Services Network LLC purchased a new position in shares of Ryan Specialty in the 3rd quarter valued at approximately $28,000. SBI Securities Co. Ltd. lifted its stake in shares of Ryan Specialty by 6,322.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company's stock valued at $30,000 after purchasing an additional 569 shares during the period. Fifth Third Bancorp lifted its stake in shares of Ryan Specialty by 65.4% in the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company's stock valued at $34,000 after purchasing an additional 242 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Ryan Specialty by 83.7% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company's stock valued at $35,000 after purchasing an additional 273 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Key Headlines Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations — Ryan reported $0.47 EPS vs. $0.43 consensus and revenue of $795.2M (up 15.2% YoY) with organic revenue growth of 11.8%. The print shows continued demand across specialty lines and improved profitability metrics. Business Wire MarketBeat
• Neutral Sentiment: Company announced a quarterly dividend of $0.13 per share (annualized yield ~1.7%), payable May 26 to holders of record May 12 — modest income sign but unlikely to materially change near-term sentiment.
• Neutral Sentiment: Full Q1 earnings call transcript is available for investors digging into segment/expense details and management commentary on pricing, reinsurance and M&A strategy. Useful for assessing sustainability of organic growth. Earnings Call Transcript
• Negative Sentiment: Wells Fargo reaffirmed an "equal weight" rating but cut its price target to $31 from $42, removing upside cushion and signaling tepid near-term conviction; that downgrade likely contributed to selling pressure. Benzinga The Fly
• Negative Sentiment: Keefe, Bruyette & Woods cut its price target to $42 from $49 but kept an "outperform" rating — the lowered target reduces upside expectations despite the buy call, and adds to negative analyst repositioning. Benzinga

Ryan Specialty Company Profile

Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.

Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.